Cargando…
Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs
Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the approaches to salt or polymorph formation do not meet the expected targets. In this article, an ove...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874831/ https://www.ncbi.nlm.nih.gov/pubmed/29370068 http://dx.doi.org/10.3390/pharmaceutics10010018 |
_version_ | 1783310240957071360 |
---|---|
author | Karagianni, Anna Malamatari, Maria Kachrimanis, Kyriakos |
author_facet | Karagianni, Anna Malamatari, Maria Kachrimanis, Kyriakos |
author_sort | Karagianni, Anna |
collection | PubMed |
description | Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the approaches to salt or polymorph formation do not meet the expected targets. In this article, an overview of pharmaceutical cocrystals will be presented, with an emphasis on the intermolecular interactions in cocrystals and the methods for their preparation. Furthermore, cocrystals of direct pharmaceutical interest, along with their in vitro properties and available in vivo data and characterization techniques are discussed, highlighting the potential of cocrystals as an attractive route for drug development. |
format | Online Article Text |
id | pubmed-5874831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-58748312018-04-02 Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs Karagianni, Anna Malamatari, Maria Kachrimanis, Kyriakos Pharmaceutics Review Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the approaches to salt or polymorph formation do not meet the expected targets. In this article, an overview of pharmaceutical cocrystals will be presented, with an emphasis on the intermolecular interactions in cocrystals and the methods for their preparation. Furthermore, cocrystals of direct pharmaceutical interest, along with their in vitro properties and available in vivo data and characterization techniques are discussed, highlighting the potential of cocrystals as an attractive route for drug development. MDPI 2018-01-25 /pmc/articles/PMC5874831/ /pubmed/29370068 http://dx.doi.org/10.3390/pharmaceutics10010018 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Karagianni, Anna Malamatari, Maria Kachrimanis, Kyriakos Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs |
title | Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs |
title_full | Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs |
title_fullStr | Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs |
title_full_unstemmed | Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs |
title_short | Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs |
title_sort | pharmaceutical cocrystals: new solid phase modification approaches for the formulation of apis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874831/ https://www.ncbi.nlm.nih.gov/pubmed/29370068 http://dx.doi.org/10.3390/pharmaceutics10010018 |
work_keys_str_mv | AT karagiannianna pharmaceuticalcocrystalsnewsolidphasemodificationapproachesfortheformulationofapis AT malamatarimaria pharmaceuticalcocrystalsnewsolidphasemodificationapproachesfortheformulationofapis AT kachrimaniskyriakos pharmaceuticalcocrystalsnewsolidphasemodificationapproachesfortheformulationofapis |